William R. Waud - Concepedia

Author

William R. Waud

Southern Research Institute

Also Known As

W R Waud, W. R. Waud, W.R Waud, W.R. Waud, William R Waud, William R. Waud

110

Publications

3.4K

Citations

H-Index

Concepts

All Affiliations

Southern Research Institute University of Alabama at Birmingham Cornell University Duke Medical Center Duke University Hospital

About

William R. Waud is an author at Southern Research Institute specializing in medicine, pharmacology, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	38	2.1K
2	Biochemistry	16	21	1.5K
3	Natural Sciences	13	16	602
4	Health Sciences	6	6	708
5	Engineering	5	5	370

William R. Waud

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
A new purification procedure for bovine milk xanthine oxidase: Effect of proteolysis on the subunit structure William R. Waud, Frank Brady, Ralph D. Wiley, Archives of Biochemistry and Biophysics EngineeringBiochemistryBiotechnologyNew Purification ProcedureSubunit Structure	1975	235
Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway Wenyan Lü, Cuihong Lin, Michael J. Roberts, PLoS ONE	2011	221
The mechanism of conversion of rat liver xanthine dehydrogenase from an NAD+-dependent form (type D) to an O2-dependent form (type O) William R. Waud, K.V. Rajagopalan Archives of Biochemistry and Biophysics Type OCellular EnzymologyBiochemistryLiver PhysiologyPhysiology	1976	215
Purification and properties of the NAD+-dependent (type D) and O2-dependent (type O) forms of rat liver xanthine dehydrogenase William R. Waud, K.V. Rajagopalan Archives of Biochemistry and Biophysics Type OCellular EnzymologyBiochemistryLiver PhysiologyPhysiology	1976	208
Inborn errors of molybdenum metabolism: combined deficiencies of sulfite oxidase and xanthine dehydrogenase in a patient lacking the molybdenum cofactor. Jean L. Johnson, William R. Waud, K.V. Rajagopalan, Proceedings of the National Academy of Sciences PathologyMolybdenum CofactorPlasma Molybdenum ConcentrationRedox BiologyOxidative Stress	1980	167
Preclinical antitumor activity of temozolomide in mice: efficacy against human brain tumor xenografts and synergism with 1,3-bis(2-chloroethyl)-1-nitrosourea. Jacqueline Plowman, William R. Waud, Antonis D. Koutsoukos, PubMed Tumor Growth DelayU251 ModelPharmacotherapyHigh-grade GliomasGlioma	1994	132
Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells. William R. Waud PubMed Platinum DamageChemical BiologyTumor BiologyDifferential UptakeDrug Resistance	1987	102
Superior in vivo experimental antitumour activity of vinflunine, relative to vinorelbine, in a panel of human tumour xenografts Bridget T. Hill, Heinz‐Herbert Fiebig, William R. Waud, European Journal of Cancer OncologyHuman Tumour XenograftsMedicinePathologyPharmacotherapy	1999	91
Sorafenib is efficacious and tolerated in combination with cytotoxic or cytostatic agents in preclinical models of human non-small cell lung carcinoma Christopher A. Carter, Charles Chen, Cheryl Brink, Cancer Chemotherapy and Pharmacology OncologyPreclinical ModelsMedicineCytostatic AgentsBronchial Neoplasm	2006	87
SJG-136 (NSC 694501), A Novel Rationally Designed DNA Minor Groove Interstrand Cross-Linking Agent with Potent and Broad Spectrum Antitumor Activity Michael C. Alley, Melinda G. Hollingshead, Christine Pacula-Cox, Cancer Research Hollow Fiber AssaysMolecular BiologyNsc 694501Tumor BiologyMedicinal Chemistry	2004	83

Page 1